Fulgent Genetics (FLGT) Gross Profit (2016 - 2025)
Fulgent Genetics' Gross Profit history spans 11 years, with the latest figure at $32.6 million for Q4 2025.
- For Q4 2025, Gross Profit rose 2.3% year-over-year to $32.6 million; the TTM value through Dec 2025 reached $130.9 million, up 22.07%, while the annual FY2025 figure was $130.9 million, 22.07% up from the prior year.
- Gross Profit for Q4 2025 was $32.6 million at Fulgent Genetics, down from $35.5 million in the prior quarter.
- Across five years, Gross Profit topped out at $285.4 million in Q1 2021 and bottomed at $13.0 million in Q4 2022.
- The 5-year median for Gross Profit is $33.5 million (2025), against an average of $74.3 million.
- The largest annual shift saw Gross Profit skyrocketed 7620.62% in 2021 before it tumbled 93.15% in 2022.
- A 5-year view of Gross Profit shows it stood at $189.5 million in 2021, then crashed by 93.15% to $13.0 million in 2022, then skyrocketed by 94.26% to $25.2 million in 2023, then increased by 26.24% to $31.8 million in 2024, then grew by 2.3% to $32.6 million in 2025.
- Per Business Quant, the three most recent readings for FLGT's Gross Profit are $32.6 million (Q4 2025), $35.5 million (Q3 2025), and $34.4 million (Q2 2025).